환자 모니터링 기기 : 시장 인사이트, 경쟁 구도 및 시장 예측(-2034년)

Patient Monitoring Devices Market Summary

Overview:

• The Patient Monitoring Devices market is estimated at USD 56.4 billion in 2025 and is projected to reach USD 137.15 billion by 2034. Growth is anchored in the rising global burden of chronic and cardiovascular disease, rapid adoption of AI-enabled and wireless monitoring platforms, and the accelerating shift of continuous monitoring from acute hospital settings into ambulatory and home care.
• The global Patient Monitoring Devices market is growing at a CAGR of 10.38% during the forecast period from 2026 to 2034.
• By type of devices, the blood glucose monitoring systems segment dominated the Patient Monitoring Devices market with a 26% share in 2025.
• By application, the cardiology segment dominated the Patient Monitoring Devices market with a 38% share in 2025.
• By end-user, the hospitals & clinics segment dominated the Patient Monitoring Devices market with a 46% share in 2025.
• North America dominated the global Patient Monitoring Devices market revenue with a 43% share in 2025, representing the highest regional market share globally.

A patient monitoring device is a diagnostic or therapeutic support instrument that continuously or intermittently measures, records, and transmits a patient's physiological parameters, including cardiac activity, neurological status, respiratory function, hemodynamic status, and blood glucose levels, to support clinical decision-making and early detection of deterioration. Because acutely and chronically ill patients require uninterrupted surveillance across the care continuum, hospitals, ambulatory surgical centers, and home care providers rely on a broad ecosystem of neuromonitoring, cardiac monitoring, respiratory monitoring, hemodynamic monitoring, blood glucose monitoring, and multi-parameter monitoring devices. The market is organized by type of devices across neuromonitoring, cardiac monitoring, respiratory monitoring, hemodynamic monitoring, blood glucose monitoring systems, multi-parameter monitoring devices, and others; by application across cardiology, neurology, respiratory, and other clinical specialties; and by end-user across hospitals and clinics, ambulatory surgical centers, home care settings, and others. Driven by the rising global prevalence of cardiovascular disease, diabetes, and respiratory disorders, the rapid integration of artificial intelligence, wireless connectivity, and cloud-based analytics into monitoring platforms, and the accelerating adoption of remote patient monitoring and home-based care models, patient monitoring devices have become essential infrastructure underpinning continuous, data-driven patient care.

Patient Monitoring Devices Market Key Growth Drivers

• The rising global burden of chronic disease is expanding demand for continuous monitoring, with more than half of U.S. adults living with hypertension and global diabetes prevalence projected to rise sharply through 2050.
• The growing geriatric population is increasing the volume of patients requiring cardiac, respiratory, and multi-parameter surveillance across hospital, ambulatory, and home care settings.
• Rapid advancement of wearable sensors, wireless connectivity, and AI-powered analytics is improving the accuracy, portability, and predictive capability of monitoring devices, exemplified by GE HealthCare's Carevance monitor and Masimo's wearable Radius VSM platform.
• Accelerating adoption of remote patient monitoring and telehealth, reinforced by favorable reimbursement policies and government digital-health initiatives, is extending continuous monitoring beyond the hospital.
• A structural shift toward home healthcare and self-monitoring is expanding consumer demand for blood pressure monitors, pulse oximeters, and continuous glucose monitors.
• Rising healthcare expenditure and expanding hospital infrastructure, particularly across Asia-Pacific, are increasing the installed base of multi-parameter and bedside monitoring systems.
• Sustained new-product launches, FDA clearances, and strategic partnerships among leading medical technology companies are broadening monitoring capability and intensifying competitive innovation.

Key Companies in Patient Monitoring Devices Market

The competitive landscape is led by the following active device manufacturers:

• Medtronic
• GE Healthcare
• Philips Healthcare
• Abbott Laboratories
• Siemens Healthineers
• Nihon Kohden Corporation
• Masimo Corporation
• Omron Healthcare Co., Ltd.
• Smiths Medical
• Hillrom

Factors Contributing to the Growth of the Patient Monitoring Devices Market

Market Drivers

Rising Global Burden of Chronic and Cardiovascular Disease

The most powerful driver of the Patient Monitoring Devices market is the escalating global burden of cardiovascular disease, diabetes, and respiratory disorders, which require continuous or frequent physiological surveillance. Hypertension alone affects roughly half of U.S. adults and remains the leading modifiable risk factor for cardiovascular events worldwide, while global diabetes prevalence continues to climb steeply. New clinical guidance from bodies such as the American Heart Association and American College of Cardiology in 2025 has further emphasized earlier detection and closer at-home blood pressure tracking. As chronic disease prevalence rises across both developed and emerging economies, demand for cardiac, hemodynamic, respiratory, and glucose monitoring devices expands directly, anchoring market growth through 2034.

Growing Geriatric Population and Rising Hospitalization Needs

The expanding global geriatric population is increasing the volume of patients who require continuous vital-sign and multi-parameter surveillance, both during hospitalization and in post-acute and home settings. Older patients are disproportionately affected by cardiovascular disease, neurological disorders, and respiratory illness, and are more likely to experience clinical deterioration that benefits from early, continuous detection. As life expectancy rises and healthcare systems prioritize proactive geriatric care, hospitals and home care providers are expanding their installed base of bedside, wearable, and multi-parameter monitors to manage this growing patient population, sustaining demand for monitoring devices across the forecast period.

Market Restraints

Despite strong momentum, the Patient Monitoring Devices market faces material constraints. The relatively high upfront cost of advanced multi-parameter, hemodynamic, and neuromonitoring systems limits adoption among smaller hospitals, ambulatory centers, and providers in price-sensitive emerging markets. Data privacy, cybersecurity, and interoperability concerns complicate the integration of wireless and cloud-connected monitoring devices with hospital IT infrastructure and electronic health records, slowing deployment in some health systems. Alarm fatigue and false-positive alerts remain a persistent clinical challenge, as nurses can spend a substantial share of their shifts responding to signals that require no intervention, prompting the need for continued investment in smarter alarm-management software. Reimbursement for remote and home-based monitoring remains uneven across geographies, and stringent, evolving regulatory requirements around device accuracy, cybersecurity, and clinical validation lengthen approval timelines and raise development costs. A shortage of trained biomedical and clinical informatics personnel in some regions further constrains the pace of large-scale monitoring system deployment. Together, these cost, interoperability, regulatory, and workforce barriers temper the pace of growth, even as the underlying drivers of chronic disease burden, technological innovation, and home-care expansion remain firmly intact.

Patient Monitoring Devices Market Segment Analysis

The patient monitoring devices by market by type of devices (neuromonitoring devices, cardiac monitoring devices, respiratory monitoring devices, hemodynamic monitoring devices, blood glucose monitoring systems, multi-parameter monitoring devices, and others), application (cardiology, neurology, respiratory, and others), end-users (hospitals & clinics, ambulatory surgical centers, home care settings, and others), and geography (North America, Europe, Asia-Pacific, and Rest of World).

By Type of Devices

Dominant Subsegment: Blood Glucose Monitoring Systems.

Dominant: Blood Glucose Monitoring Systems ~ 26%

The blood glucose monitoring systems segment accounted for 26% of the Patient Monitoring Devices market in 2025. Blood glucose monitoring systems are the leading device type because the global diabetic population continues to expand steeply, requiring frequent to continuous glucose tracking through both point-of-care meters and wearable continuous glucose monitors. The commercial success and rapid iteration of continuous glucose monitoring platforms, combined with the shift of diabetes management from clinical settings into daily home use, has made this segment the workhorse of the home-monitoring channel. Cardiac monitoring devices represent a close and fast-growing category, propelled by the rising prevalence of arrhythmias and cardiovascular disease and by wearable ECG innovation, while multi-parameter monitoring devices remain the standard of care in hospital wards and intensive care units. While cardiac and multi-parameter monitoring devices are growing rapidly on the back of hospital modernization and AI-enabled analytics, the sheer volume, frequency, and consumer accessibility of glucose monitoring secure the segment's leadership across the forecast period.

By Application

Dominant Subsegment: Cardiology.

Dominant: Cardiology ~ 38%

The cardiology segment accounted for 38% of the Patient Monitoring Devices market in 2025. Cardiology is the leading application because cardiovascular disease remains the leading cause of morbidity and mortality worldwide, driving high-volume, recurring demand for ECG monitors, cardiac telemetry, hemodynamic monitors, and wearable cardiac patches across hospitals, ambulatory centers, and the home. New clinical guidelines emphasizing earlier detection of hypertension and atrial fibrillation, together with the rapid rollout of AI-powered AFib-detection features by companies such as Omron Healthcare and Masimo, are reinforcing sustained demand for cardiology-focused monitoring. Neurology is the fastest-growing application as neuromonitoring adoption expands into stroke care, epilepsy management, and intraoperative monitoring, while respiratory monitoring benefits from the ongoing burden of chronic respiratory disease. Nonetheless, the breadth, recurrence, and clinical urgency of cardiovascular monitoring keep cardiology the dominant application through the forecast period.

Patient Monitoring Devices Market Region Analysis

Dominant Region: North America

North America accounted for 43% of the global Patient Monitoring Devices market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects a high prevalence of chronic disease, widespread adoption of advanced healthcare technologies, mature telehealth and reimbursement infrastructure, and the concentrated presence of leading monitoring device manufacturers including Medtronic, GE HealthCare, Abbott, and Masimo. The United States leads on the strength of favorable reimbursement for remote physiologic monitoring, extensive hospital modernization investment, and rapid clinical adoption of wearable and AI-enabled monitoring platforms, exemplified by the FDA clearance of new wearable cardiac and respiratory monitoring devices throughout 2025 and 2026. Strong regulatory clarity, deep capital markets, and sustained new product launches anchor the region's continued leadership across the forecast period.

Fastest Growing Region: Asia-Pacific

Asia-Pacific is the fastest-growing region in the Patient Monitoring Devices market. The region's elevated CAGR is driven by a large and aging patient population, rising chronic disease incidence, rapid hospital infrastructure expansion, and growing healthcare expenditure across China, Japan, India, South Korea, and Australia. China is expanding hospital-grade monitoring capacity as part of broader healthcare modernization, Japan continues to lead in precision monitoring technology through manufacturers such as Nihon Kohden, and India is emerging as a high-volume, cost-sensitive market for home blood pressure and glucose monitoring devices. Government investment in digital health infrastructure, expanding insurance coverage, and rising consumer awareness of preventive care are accelerating adoption, positioning Asia-Pacific as the principal source of incremental market growth over the forecast period.

Regional Commentary

North America

North America accounted for 43% of the global Patient Monitoring Devices market revenue in 2025. The United States dominates on the strength of its chronic disease burden, mature reimbursement and telehealth infrastructure, and the concentrated presence of leading manufacturers, while continued FDA clearances for wearable and AI-enabled monitoring devices reinforce the region's leadership.

Europe

Europe is a large and technologically advanced regional market, supported by strong national healthcare systems, established CE-mark regulatory pathways, and growing adoption of digital health and remote monitoring initiatives. Recent developments, including Philips' FDA and CE-cleared monitoring innovations and its expanding enterprise monitoring deployments across major European health systems, reinforce the region's role as a center of clinical monitoring innovation across Germany, France, the United Kingdom, Italy, and Spain.

Asia-Pacific

Asia-Pacific is the fastest-growing region, propelled by a large aging population, rising cardiovascular and diabetes prevalence, and rapid hospital infrastructure build-out across China, Japan, India, South Korea, and Australia. Japan's precision-monitoring leadership through Nihon Kohden, China's hospital modernization programs, and India's fast-growing home-monitoring consumer base are accelerating regional adoption and manufacturing investment.

Rest of World

The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. Expanding hospital infrastructure, rising prevalence of chronic and cardiovascular disease, and growing government investment in healthcare access are gradually broadening adoption of patient monitoring devices, while international partnerships and distribution expansion by global manufacturers support the build-out of regional monitoring capacity.

Patient Monitoring Devices Market Competitive Landscape

The Patient Monitoring Devices market is classified as Moderately Consolidated. A group of large, diversified medical technology companies with broad monitoring portfolios and global distribution, including Medtronic, GE Healthcare, Philips Healthcare, and Abbott Laboratories, anchors the top tier, while specialized providers such as Masimo, Nihon Kohden, Siemens Healthineers, Omron Healthcare, Smiths Medical, and Hillrom compete through differentiated sensor technology, home-monitoring platforms, and clinical partnerships, increasing competition across the fastest-growing device categories.

The competitive landscape can be evaluated across the following dimensions:

• Market concentration: Moderately consolidated, with diversified, multi-segment medical technology leaders competing alongside specialized monitoring-technology providers.
• Leading players: Medtronic, GE Healthcare, Philips Healthcare, and Abbott Laboratories anchor the top tier through broad monitoring portfolios and global installed bases.
• Geographic reach: Leaders operate global, multi-region distribution and service networks essential for hospital and home-monitoring deployments across developed and emerging markets.
• Product portfolio strength: Top players offer end-to-end monitoring across neuromonitoring, cardiac, respiratory, hemodynamic, glucose, and multi-parameter categories, spanning hospital, ambulatory, and home settings.
• Technology partnerships: Strategic collaborations, such as the renewed multi-year Philips-Masimo partnership integrating advanced sensing parameters into Philips' IntelliVue monitors, extend technology reach and accelerate innovation.
• M&A and consolidation activity: Active consolidation, including ICU Medical's USD 2.4 billion acquisition of Smiths Medical and Baxter International's acquisition of Hillrom, has concentrated monitoring portfolios among diversified medical technology companies.
• Innovation focus: AI-powered predictive analytics, wireless and wearable monitoring, alarm-management software, and integration with electronic health records are key competitive differentiators.
• Regulatory track record: Sustained FDA clearances and CE mark approvals for new monitoring platforms, sensors, and AI-enabled features are a decisive advantage in winning provider contracts.

Patient Monitoring Devices Market Recent Developmental Activities

In October 2025, GE HealthCare received CE mark for its Carevance patient monitor, introducing a new Cardiac Output Insights application and expanding accessible, clinically reliable monitoring for European customers. Strategic significance: Strengthens GE HealthCare's hospital monitoring portfolio and reinforces its position as an integrated patient care solutions leader.

In October 2025, Nihon Kohden launched AlarmSense, a data-driven analytics solution designed to intelligently streamline hospital alarm response and combat alarm fatigue among clinical teams. Strategic significance: Extends Nihon Kohden's software and analytics capability beyond hardware monitoring, addressing a persistent clinical workflow challenge.

Patient Monitoring Devices Market Segmentation

Patient Monitoring Devices Market by Product

• Neuromonitoring Devices
• Cardiac Monitoring Devices
• Respiratory Monitoring Devices
• Hemodynamic Monitoring Devices
• Blood Glucose Monitoring Systems
• Multi-parameter Monitoring Devices
• Others

Patient Monitoring Devices Market by Application

• Cardiology
• Neurology
• Respiratory
• Others

Patient Monitoring Devices Market by End User

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Home Care Settings
• Others

Patient Monitoring Devices Market by Geography

• North America Patient Monitoring Devices Market
• United States Patient Monitoring Devices Market Size in USD million (2023-2034)
• Canada Patient Monitoring Devices Market Size in USD million (2023-2034)
• Mexico Patient Monitoring Devices Market Size in USD million (2023-2034)
• Europe Patient Monitoring Devices Market
• Germany Patient Monitoring Devices Market Size in USD million (2023-2034)
• United Kingdom Patient Monitoring Devices Market Size in USD million (2023-2034)
• France Patient Monitoring Devices Market Size in USD million (2023-2034)
• Italy Patient Monitoring Devices Market Size in USD million (2023-2034)
• Spain Patient Monitoring Devices Market Size in USD million (2023-2034)
• Rest of Europe Patient Monitoring Devices Market Size in USD million (2023-2034)
• Asia-Pacific Patient Monitoring Devices Market
• China Patient Monitoring Devices Market Size in USD million (2023-2034)
• Japan Patient Monitoring Devices Market Size in USD million (2023-2034)
• India Patient Monitoring Devices Market Size in USD million (2023-2034)
• Australia Patient Monitoring Devices Market Size in USD million (2023-2034)
• South Korea Patient Monitoring Devices Market Size in USD million (2023-2034)
• Rest of Asia-Pacific Patient Monitoring Devices Market Size in USD million (2023-2034)
• Rest of the World (RoW) Patient Monitoring Devices Market
• Middle East Patient Monitoring Devices Market Size in USD million (2023-2034)
• Africa Patient Monitoring Devices Market Size in USD million (2023-2034)
• South America Patient Monitoring Devices Market Size in USD million (2023-2034)

Key Takeaways from the Patient Monitoring Devices Market Report Study

• Market size analysis for the current patient monitoring devices market size (2025), and market forecast for 9 years (2026 to 2034).
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
• Key companies dominating the global patient monitoring devices market.
• Various opportunities available for competitors in the patient monitoring devices market space.
• What are the top-performing segments in 2025? How will these segments perform in 2034?
• Which are the top-performing regions and countries in the current patient monitoring devices market scenario?
• Which are the regions and countries where companies should concentrate their opportunities for patient monitoring devices market growth in the future?

Target audience who can benefit from this patient monitoring devices market report study

• Patient monitoring devices product providers
• Research organizations and consulting companies
• Patient monitoring devices-related organizations, associations, forums, and other alliances.
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in patient monitoring devices
• Various end-users who want to know more about the patient monitoring devices market and the latest technological developments in the patient monitoring devices market.

Frequently Asked Questions:

Q1. What is the growth rate of the Patient Monitoring Devices market?

The Patient Monitoring Devices market is projected to expand at a CAGR of 10.38% during the forecast period from 2026-2034.

Q2. What is the market size of the Patient Monitoring Devices market?

The Patient Monitoring Devices market is estimated at USD 56.4 billion in 2025 and is projected to reach USD 137.15 billion by 2034.

Q3. Which region dominates the Patient Monitoring Devices market?

North America dominated the Patient Monitoring Devices market with a 43% share of global revenue in 2025, supported by a high prevalence of chronic disease, mature telehealth and reimbursement infrastructure, and the concentrated presence of leading monitoring device manufacturers. Asia-Pacific is the fastest-growing region over the forecast period.

Q4. What are the key drivers of the Patient Monitoring Devices market?

The principal drivers are the rising global burden of chronic and cardiovascular disease; the growing geriatric population; rapid advancement of wearable, wireless, and AI-powered monitoring technology; accelerating adoption of remote patient monitoring and telehealth; favorable reimbursement policies; and growing home healthcare and self-monitoring trends.

Q5. Who are the major players in the Patient Monitoring Devices market?

The major players include Medtronic, GE Healthcare, Philips Healthcare, Abbott Laboratories, Siemens Healthineers, Nihon Kohden Corporation, Masimo Corporation, Omron Healthcare Co., Ltd., Smiths Medical, and Hillrom, among other active providers profiled in the Competitive Landscape section.

Table of Contents

1. Patient Monitoring Devices Market Report Introduction

• 1.1 Scope of the Study
• 1.2 Market Segmentation
• 1.3 Market Assumptions

2. Patient Monitoring Devices Market Executive Summary

• 2.1 Market at a Glance

3. Patient Monitoring Devices Market Key Factors Analysis

• 3.1 Patient Monitoring Devices Market Drivers
  • 3.1.1 Rising Burden of Chronic and Cardiovascular Disease
  • 3.1.2 Growing Geriatric Population
  • 3.1.3 Technological Advancement in Wearables, Wireless, and AI
  • 3.1.4 Expansion of Remote Patient Monitoring and Telehealth
• 3.2 Patient Monitoring Devices Market Restraints and Challenges
  • 3.2.1 High Cost of Advanced Monitoring Systems
  • 3.2.2 Data Privacy, Cybersecurity, and Interoperability Constraints
  • 3.2.3 Reimbursement and Regulatory Complexity
• 3.3 Patient Monitoring Devices Market Opportunities
  • 3.3.1 AI-Enabled Predictive Monitoring Scale-Up
  • 3.3.2 Emerging-Market and Home-Monitoring Expansion

4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments

5. Regulatory Analysis

• 5.1 United States
• 5.2 Europe
• 5.3 Japan
• 5.4 China

6. Patient Monitoring Devices Market Porter's Five Forces Analysis

• 6.1 Bargaining Power of Suppliers
• 6.2 Bargaining Power of Buyers
• 6.3 Threat of New Entrants
• 6.4 Threat of Substitutes
• 6.5 Competitive Rivalry

7. Patient Monitoring Devices Market Assessment

• 7.1 By Type of Devices
  • 7.1.1 Neuromonitoring Devices
  • 7.1.2 Cardiac Monitoring Devices
  • 7.1.3 Respiratory Monitoring Devices
  • 7.1.4 Hemodynamic Monitoring Devices
  • 7.1.5 Blood Glucose Monitoring Systems
  • 7.1.6 Multi-parameter Monitoring Devices
  • 7.1.7 Others
• 7.2 By Application
  • 7.2.1 Cardiology
  • 7.2.2 Neurology
  • 7.2.3 Respiratory
  • 7.2.4 Others
• 7.3 By End-User
  • 7.3.1 Hospitals & Clinics
  • 7.3.2 Ambulatory Surgical Centers
  • 7.3.3 Home Care Settings
  • 7.3.4 Others
• 7.4 By Geography
  • 7.4.1 North America
    • 7.4.1.1 United States Patient Monitoring Devices Market Size in USD million (2023-2034)
    • 7.4.1.2 Canada Patient Monitoring Devices Market Size in USD million (2023-2034)
    • 7.4.1.3 Mexico Patient Monitoring Devices Market Size in USD million (2023-2034)
  • 7.4.2 Europe
    • 7.4.2.1 Germany Patient Monitoring Devices Market Size in USD million (2023-2034)
    • 7.4.2.2 United Kingdom Patient Monitoring Devices Market Size in USD million (2023-2034)
    • 7.4.2.3 France Patient Monitoring Devices Market Size in USD million (2023-2034)
    • 7.4.2.4 Italy Patient Monitoring Devices Market Size in USD million (2023-2034)
    • 7.4.2.5 Spain Patient Monitoring Devices Market Size in USD million (2023-2034)
    • 7.4.2.6 Rest of Europe Patient Monitoring Devices Market Size in USD million (2023-2034)
  • 7.4.3 Asia-Pacific
    • 7.4.3.1 China Patient Monitoring Devices Market Size in USD million (2023-2034)
    • 7.4.3.2 Japan Patient Monitoring Devices Market Size in USD million (2023-2034)
    • 7.4.3.3 India Patient Monitoring Devices Market Size in USD million (2023-2034)
    • 7.4.3.4 Australia Patient Monitoring Devices Market Size in USD million (2023-2034)
    • 7.4.3.5 South Korea Patient Monitoring Devices Market Size in USD million (2023-2034)
    • 7.4.3.6 Rest of Asia-Pacific Patient Monitoring Devices Market Size in USD million (2023-2034)
  • 7.4.4 Rest of World
    • 7.4.4.1 Middle East Patient Monitoring Devices Market Size in USD million (2023-2034)
    • 7.4.4.2 Africa Patient Monitoring Devices Market Size in USD million (2023-2034)
    • 7.4.4.3 South America Patient Monitoring Devices Market Size in USD million (2023-2034)

8. Patient Monitoring Devices Market Competitive Landscape

• 8.1 Market Concentration and Structure
• 8.2 Competitive Positioning and Market Share Analysis (Premium Offering)

9. Patient Monitoring Devices Market Startup Funding and Investment Trends

10. Patient Monitoring Devices Market Company and Product Profiles

• 10.1 Medtronic
  • 10.1.1 Company Overview
  • 10.1.2 Company Snapshot
  • 10.1.3 Financial Overview
  • 10.1.4 Service Portfolio
  • 10.1.5 Strategic Initiatives / Entropy
• 10.2 GE Healthcare
  • 10.2.1 Company Overview
  • 10.2.2 Company Snapshot
  • 10.2.3 Financial Overview
  • 10.2.4 Product Portfolio
  • 10.2.5 Strategic Initiatives / Entropy
• 10.3 Philips Healthcare
  • 10.3.1 Company Overview
  • 10.3.2 Company Snapshot
  • 10.3.3 Financial Overview
  • 10.3.4 Product Portfolio
  • 10.3.5 Strategic Initiatives / Entropy
• 10.4 Abbott Laboratories
  • 10.4.1 Company Overview
  • 10.4.2 Company Snapshot
  • 10.4.3 Financial Overview
  • 10.4.4 Product Portfolio
  • 10.4.5 Strategic Initiatives / Entropy
• 10.5 Siemens Healthineers
  • 10.5.1 Company Overview
  • 10.5.2 Company Snapshot
  • 10.5.3 Financial Overview
  • 10.5.4 Product Portfolio
  • 10.5.5 Strategic Initiatives / Entropy
• 10.6 Nihon Kohden Corporation
  • 10.6.1 Company Overview
  • 10.6.2 Company Snapshot
  • 10.6.3 Financial Overview
  • 10.6.4 Product Portfolio
  • 10.6.5 Strategic Initiatives / Entropy
• 10.7 Masimo Corporation
  • 10.7.1 Company Overview
  • 10.7.2 Company Snapshot
  • 10.7.3 Financial Overview
  • 10.7.4 Product Portfolio
  • 10.7.5 Strategic Initiatives / Entropy
• 10.8 Omron Healthcare Co., Ltd.
  • 10.8.1 Company Overview
  • 10.8.2 Company Snapshot
  • 10.8.3 Financial Overview
  • 10.8.4 Product Portfolio
  • 10.8.5 Strategic Initiatives / Entropy
• 10.9 Smiths Medical
  • 10.9.1 Company Overview
  • 10.9.2 Company Snapshot
  • 10.9.3 Financial Overview
  • 10.9.4 Product Portfolio
  • 10.9.5 Strategic Initiatives / Entropy
• 10.10 Hillrom
  • 10.10.1 Company Overview
  • 10.10.2 Company Snapshot
  • 10.10.3 Financial Overview
  • 10.10.4 Product Portfolio
  • 10.10.5 Strategic Initiatives / Entropy

For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer and Contact Us